Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

This study has been completed.
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Amgen Identifier:
First received: May 16, 2005
Last updated: May 22, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2006
  Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)